BIBLIOGRAPHY 669 



62a. Baduel, C. L'infezione diplococcica (diplococco di Fraenkel). 



Contributo di osservazioni cliniche e batteriologiche. Riforma 



med., 1(15): 170, Jan. 19, 1899. 

 62b. Baermann, G. Ueber Pneumokokken-Pneumonie und deren 



Chemotherapie. Ztschr. f. Exper. Path. u. Therap., 15(3): 476, 



March 16, 1914. 



63. Baerthlein, K. uber Mutationserscheinungen bei Bakterien. Arb. 

 a. d. k. Gsndhtsamte, 40(4) : 433, Sept. 1912. 



64. Bailey, G. H., and Shorb, M. S. Heterophile antigen in pneumo- 



cocci. Am. J. Hyg., 13(3) : 831, May 1931 387 



65. Bailey, G. H., and Shorb, M. S. Chemical and immunological 

 properties of pneumococci and other heterophile antibodies. Am. 



J. Hyg., 17(2) :329, Mar. 1933 387 



66. Bailey, G. H., and Shorb, M. S. Immunological relationships of 

 pneumococci and other heterophile antigens and biological signifi- 

 cance in pneumococcus infection. Am. J. Hyg., 17(2): 358, Mar. 



1933 288 



67. Bailey, S. F. "Hormone Mediums." Simple method of prepara- 

 tion and value of hormone blood agar for preserving pneumococci 



and streptococci. J. Infect. Dis., 36(3) : 340, Mar. 1925 44 



68. Baldwin, H. S., and Rhoades, D. R. Studies on pneumococcus im- 

 munity. VII. The protective substance in pneumococcus pneu- 

 monia with special reference to bacteriemia and specific treatment. 

 Hygienic Laboratory Bulletin, No. 141 : 43, Apr. 1925 439 



69. Baldwin, H. S., and Rhoades, D. R. The use of optochin base in 

 the treatment of lobar pneumonia. Hygienic Laboratory Bulletin, 



No. 141:69, Apr. 1925 514 



70. Banzhaf, E. J. The distribution of the immune bodies occurring 

 in Types I, II and III antipneumococcus serum. Proc. Soc. Exper. 



Biol. & Med., 22(6) :329, Mar. 1925 412,548,549,550,551,553 



71. Banzhaf, E. J., and Curphey, T. J. A modified method for the 

 production of antipneumococcus serum in horses. Proc. Soc. 

 Exper. Biol. & Med., 28(3) :279, Dec. 1930 338 



72. Banzhaf, E. J., and Klein, A. J. A practical method for concen- 

 trating chill free pneumococcus antibodies from sera without use 

 of salt precipitations. Proc. Soc. Exper. Biol. & Med., 28(3) : 276, 



Dec 1930 549, 550, 552, 563 



73. Banzhaf, E. J., and Klein, A. J. A practical method for concen- 

 trating chill free pneumococcus antibodies from plasma without 

 use of salt precipitations. Proc. Soc. Exper. Biol. & Med., 28(3): 

 278, Dec. 1930. 



74. Barach, A. L. Rate of development of pneumococcus immunity. 



Proc. Soc. Exper. Biol. & Med., 25(7) :558, Apr. 1928 336,411,490 



75. Barach, A. L. Factors involved in the production of immunity 

 with pneumococcus vaccine. I. Active and passive immunity dur- 

 ing the first seven days after the injection of antigen. J. Exper. 



Med., 48(1) :83, July 1928 327, 336, 484, 490, 526, 541 



76. Barach, A. L. Factors involved in the production of immunity 



